VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences for up to $129 Million plus Royalties to Develop a Functional Cure for Hepatitis B
Stock Information for VBI Vaccines Inc.
Loading
Please wait while we load your information from QuoteMedia.